Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥29.62, the stock trades at a trailing P/E ratio of 75.2x. Average trailing P/E is 47x in the Chemicals industry in China. Total returns to shareholders of 180% over the past three years. Declared Dividend • Jun 04
Dividend of CN¥0.13 announced Shareholders will receive a dividend of CN¥0.13. Ex-date: 5th June 2026 Payment date: 5th June 2026 Dividend yield will be 0.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 7.3% per year over the past 9 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 63% to shift the payout ratio to a potentially unsustainable range, which is more than the 12% EPS decline seen over the last 5 years. New Risk • Jun 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.4% average weekly change). Valuation Update With 7 Day Price Move • May 14
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥20.94, the stock trades at a trailing P/E ratio of 53.1x. Average trailing P/E is 52x in the Chemicals industry in China. Total returns to shareholders of 89% over the past three years. Reported Earnings • Apr 23
Full year 2025 earnings released: EPS: CN¥0.40 (vs CN¥0.43 in FY 2024) Full year 2025 results: EPS: CN¥0.40 (down from CN¥0.43 in FY 2024). Revenue: CN¥2.15b (down 11% from FY 2024). Net income: CN¥166.9m (down 5.2% from FY 2024). Profit margin: 7.8% (up from 7.3% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 10% per year. Ankündigung • Apr 23
Lily Group Co., Ltd., Annual General Meeting, May 19, 2026 Lily Group Co., Ltd., Annual General Meeting, May 19, 2026, at 14:00 China Standard Time. Location: 17F, No. 518, Pinglan Road, Xiaoshan District, Hangzhou, Zhejiang China Ankündigung • Mar 30
Lily Group Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Lily Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 New Risk • Mar 08
New major risk - Revenue and earnings growth Earnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 15% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Valuation Update With 7 Day Price Move • Jan 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥19.00, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 46% over the past three years. Ankündigung • Dec 26
Lily Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 23, 2026 Lily Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 23, 2026 Valuation Update With 7 Day Price Move • Nov 28
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥17.00, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years. Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment improves as stock rises 27% After last week's 27% share price gain to CN¥19.39, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 55% over the past three years. New Risk • Nov 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.8% average weekly change). Reported Earnings • Oct 29
Third quarter 2025 earnings released: EPS: CN¥0.082 (vs CN¥0.11 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.082 (down from CN¥0.11 in 3Q 2024). Revenue: CN¥512.4m (down 10% from 3Q 2024). Net income: CN¥35.9m (down 18% from 3Q 2024). Profit margin: 7.0% (down from 7.6% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥15.83, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 52% over the past three years. Ankündigung • Sep 30
Lily Group Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025 Lily Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025 New Risk • Sep 03
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.8% average weekly change). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Ankündigung • Jun 30
Lily Group Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025 Lily Group Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025 Valuation Update With 7 Day Price Move • Jun 24
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥13.54, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 36% over the past three years. New Risk • Jun 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.2% average weekly change). Valuation Update With 7 Day Price Move • Jun 10
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥12.82, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 37% over the past three years. Declared Dividend • Jun 02
Dividend of CN¥0.15 announced Dividend of CN¥0.15 is the same as last year. Ex-date: 9th June 2025 Payment date: 9th June 2025 Dividend yield will be 1.5%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (34% earnings payout ratio) and cash flows (20% cash payout ratio). The dividend has increased by an average of 10% per year over the past 8 years. However, payments have been volatile during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 27
First quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.10 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.10 in 1Q 2024). Revenue: CN¥568.7m (down 3.6% from 1Q 2024). Net income: CN¥45.8m (up 13% from 1Q 2024). Profit margin: 8.1% (up from 6.9% in 1Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Ankündigung • Apr 26
Lily Group Co., Ltd., Annual General Meeting, May 19, 2025 Lily Group Co., Ltd., Annual General Meeting, May 19, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Hangzhou, Zhejiang China Ankündigung • Mar 28
Lily Group Co., Ltd. to Report Q1, 2025 Results on Apr 26, 2025 Lily Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 26, 2025 Valuation Update With 7 Day Price Move • Mar 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥11.15, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 5.5% over the past three years. Ankündigung • Dec 27
Lily Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 26, 2025 Lily Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 26, 2025 Reported Earnings • Oct 28
Third quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.07 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.11 (up from CN¥0.07 in 3Q 2023). Revenue: CN¥570.6m (down 3.9% from 3Q 2023). Net income: CN¥43.6m (up 65% from 3Q 2023). Profit margin: 7.6% (up from 4.5% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Ankündigung • Sep 30
Lily Group Co., Ltd. to Report Q3, 2024 Results on Oct 28, 2024 Lily Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 28, 2024 Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to CN¥10.32, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 11% over the past three years. Reported Earnings • Aug 23
Second quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.089 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.14 (up from CN¥0.089 in 2Q 2023). Revenue: CN¥631.1m (up 9.1% from 2Q 2023). Net income: CN¥59.6m (up 52% from 2Q 2023). Profit margin: 9.4% (up from 6.8% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Ankündigung • Jun 28
Lily Group Co., Ltd. to Report First Half, 2024 Results on Aug 23, 2024 Lily Group Co., Ltd. announced that they will report first half, 2024 results on Aug 23, 2024 Valuation Update With 7 Day Price Move • May 24
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥11.75, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 3.7% over the past three years. Valuation Update With 7 Day Price Move • May 07
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥9.69, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years. Ankündigung • May 01
Lily Group Co., Ltd., Annual General Meeting, May 20, 2024 Lily Group Co., Ltd., Annual General Meeting, May 20, 2024, at 14:00 China Standard Time. Location: 17F, No. 520, Pinglan Road, Xiaoshan District, Hangzhou, Zhejiang China Reported Earnings • Apr 30
Full year 2023 earnings: EPS in line with expectations, revenues disappoint Full year 2023 results: EPS: CN¥0.29 (down from CN¥0.52 in FY 2022). Revenue: CN¥2.28b (down 7.5% from FY 2022). Net income: CN¥120.2m (down 44% from FY 2022). Profit margin: 5.3% (down from 8.7% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.2% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 30% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to CN¥8.95, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 28% over the past three years. Ankündigung • Mar 30
Lily Group Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Lily Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 30, 2024 Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥7.45, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years. Ankündigung • Dec 30
Lily Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 30, 2024 Lily Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Aug 31
Second quarter 2023 earnings released: EPS: CN¥0.089 (vs CN¥0.20 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.089 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥578.3m (down 22% from 2Q 2022). Net income: CN¥39.3m (down 52% from 2Q 2022). Profit margin: 6.8% (down from 11% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year. Upcoming Dividend • Jun 19
Upcoming dividend of CN¥0.21 per share at 1.4% yield Eligible shareholders must have bought the stock before 26 June 2023. Payment date: 26 June 2023. Payout ratio is a comfortable 41% and the cash payout ratio is 91%. Trailing yield: 1.4%. Lower than top quartile of Chinese dividend payers (2.0%). Lower than average of industry peers (1.9%). Reported Earnings • Apr 24
Full year 2022 earnings: EPS and revenues miss analyst expectations Full year 2022 results: EPS: CN¥0.67 (down from CN¥0.99 in FY 2021). Revenue: CN¥2.47b (flat on FY 2021). Net income: CN¥214.5m (down 31% from FY 2021). Profit margin: 8.7% (down from 13% in FY 2021). Revenue missed analyst estimates by 5.1%. Earnings per share (EPS) also missed analyst estimates by 15%. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥16.42, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 6.5% over the past three years. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.13 (down from CN¥0.20 in 3Q 2021). Revenue: CN¥541.1m (down 7.6% from 3Q 2021). Net income: CN¥39.2m (down 39% from 3Q 2021). Profit margin: 7.2% (down from 11% in 3Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥16.16, the stock trades at a trailing P/E ratio of 16.9x. Average trailing P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 1.2% over the past three years. Reported Earnings • Aug 26
Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.26 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.26 (vs CN¥0.26 in 2Q 2021). Revenue: CN¥740.8m (up 16% from 2Q 2021). Net income: CN¥82.1m (flat on 2Q 2021). Profit margin: 11% (down from 13% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 01
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥15.41, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 29x in the Chemicals industry in China. Total returns to shareholders of 8.6% over the past three years. Reported Earnings • Apr 29
First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.24 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.21 (down from CN¥0.24 in 1Q 2021). Revenue: CN¥646.3m (up 8.4% from 1Q 2021). Net income: CN¥66.8m (down 11% from 1Q 2021). Profit margin: 10% (down from 13% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 01
Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.23 in 3Q 2020) The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥585.9m (up 14% from 3Q 2020). Net income: CN¥64.4m (down 13% from 3Q 2020). Profit margin: 11% (down from 14% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥15.44, the stock trades at a trailing P/E ratio of 15.6x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 49% over the past three years. Reported Earnings • Aug 26
Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.23 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥641.3m (up 24% from 2Q 2020). Net income: CN¥82.4m (up 15% from 2Q 2020). Profit margin: 13% (down from 14% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 17% per year. Reported Earnings • Apr 17
Full year 2020 earnings released: EPS CN¥0.82 (vs CN¥0.72 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥2.01b (up 1.2% from FY 2019). Net income: CN¥259.6m (up 14% from FY 2019). Profit margin: 13% (up from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 16% per year. Is New 90 Day High Low • Jan 27
New 90-day low: CN¥13.86 The company is down 5.0% from its price of CN¥14.62 on 29 October 2020. The Chinese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. Is New 90 Day High Low • Dec 16
New 90-day low: CN¥13.90 The company is down 10.0% from its price of CN¥15.52 on 17 September 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Oct 30
New 90-day low: CN¥14.15 The company is down 19% from its price of CN¥17.37 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥229.5m, up 7.6% from the prior year. Total revenue was CN¥1.91b over the last 12 months, down 1.5% from the prior year. Is New 90 Day High Low • Sep 24
New 90-day low: CN¥14.88 The company is down 15% from its price of CN¥17.51 on 24 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.